COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?

Detalles Bibliográficos
Autores principales: Thangaraju, Pugazhenthan, gurunthalingam, Meenalotchini Prakash, venkatesan, Sajitha, Thangaraju, Eswaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211657/
https://www.ncbi.nlm.nih.gov/pubmed/32451256
http://dx.doi.org/10.1016/j.jiph.2020.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211657/
https://www.ncbi.nlm.nih.gov/pubmed/32451256
http://dx.doi.org/10.1016/j.jiph.2020.05.006

Ejemplares similares